A battery of diagnostic tests is often required to differentiate aseptic loosening from periprosthetic infection since the
gold standard remains elusive. We designed a prospective study to determine the accuracy of fluorodeoxyglucose positron emission
tomography (FDG-PET) imaging in diagnosing periprosthetic infection in a large multicenter setting. One hundred and thirteen
patients with 127 painful hip prostheses were evaluated by FDG-PET. Images were considered positive for infection if PET demonstrated
increased FDG activity at the bone-prosthesis interface of the femoral component. A combination of preoperative tests, intraoperative
findings, histopathology, and clinical followup constituted the gold standard for diagnosing infection. Among the 35 positive
PET scans, 28 hips were confirmed infected according to our criteria for diagnosing periprosthetic infection. Of the 92 hip
prostheses with negative FDG-PET findings, 87 were considered aseptic. The sensitivity, specificity, positive and negative
predictive values for FDG-PET were 0.85 (28 of 33), 0.93 (87 of 94), 0.80 (28 of 35), and 0.95 (87 of 92), respectively. The
overall accuracy of this novel noninvasive imaging modality reached 0.91 (115 of 127). Based on our results, FDG-PET appears
a promising and accurate diagnostic tool for distinguishing septic from aseptic painful hip prostheses.
Level of Evidence: Level II, diagnostic study. See Guidelines for Authors for a complete description of levels of evidence.
One of the authors (JP) has received research funding from Stryker Orthopedics.
Each author certifies that his or her institution has approved the human protocol for this investigation, that all investigations
were conducted in conformity with ethical principles of research, and that informed consent for participation in the study
was obtained.